Loading clinical trials...
Loading clinical trials...
Phase II Study of Temsirolimus and Irinotecan in Chemotherapy Refractory Patients With KRAS Mutated Metastatic Colorectal Cancer
Conditions
Interventions
Irinotecan
Temsirolimus
Locations
2
Denmark
Rigshospitalet, Department of Oncology
Copenhagen, Denmark
Vejle Hospital, Dept. of Oncology
Vejle, Denmark
Start Date
March 1, 2009
Primary Completion Date
January 1, 2011
Completion Date
June 1, 2011
Last Updated
June 8, 2011
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Vejle Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions